The effect of SOX17, MACC1 and c-Met expression in ESCC on prognosis
暂无分享,去创建一个
Yan Shi | Hui Wang | Liping Su | Shanshan Xu | Wenjing Zhang | Wenying Liu | Yuqing Ma | Mengyan Li | Chao Li | G. Abulajiang
[1] S. Pothula,et al. Targeting HGF/c-MET Axis in Pancreatic Cancer , 2020, International journal of molecular sciences.
[2] Y. Kanki,et al. Molecular mechanistic insights: The emerging role of SOXF transcription factors in tumorigenesis and development. , 2020, Seminars in cancer biology.
[3] R. Jauch,et al. SOX17 in cellular reprogramming and cancer. , 2020, Seminars in cancer biology.
[4] Lixia Yang,et al. Delivery of BR2‐SOX17 fusion protein can inhibit cell survival, proliferation, and invasion in gastric cancer cells through regulating Klotho gene expression , 2020, Cell biology international.
[5] D. Richardson,et al. The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents. , 2020, Biochimica et biophysica acta. General subjects.
[6] G. Zheng,et al. Expression of MACC1 protein in gastric cancer and its effect on proliferation and invasion of gastric cancer cells. , 2020, Cellular and molecular biology.
[7] W. Mao,et al. [Epidemiological characteristic and current status of surgical treatment for esophageal cancer by analysis of national registry database]. , 2020, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[8] J. Marin,et al. MRP3‐Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression , 2019, Hepatology.
[9] Hui Wang,et al. The expression and prognostic value of SOX2, β-catenin and survivin in esophageal squamous cell carcinoma. , 2019, Future oncology.
[10] Masayuki Watanabe,et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer , 2019, Surgery Today.
[11] H. Park,et al. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC) , 2019, Clinical Epigenetics.
[12] A. Avan,et al. The potential therapeutic and prognostic impacts of the c‐MET/HGF signaling pathway in colorectal cancer , 2019, IUBMB life.
[13] Wei-Dong Chen,et al. HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers , 2018, International journal of molecular sciences.
[14] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[15] Jun Li,et al. MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma. , 2017, Oncology reports.
[16] X. Wan,et al. SOX17 is a tumor suppressor in endometrial cancer , 2016, Oncotarget.
[17] R. Zeillinger,et al. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype , 2016, Cell adhesion & migration.
[18] Jinlin Hu,et al. C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome , 2016, Journal of Cancer.
[19] H. Sasano,et al. c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target , 2015, BMC Cancer.
[20] H. Nakagawa,et al. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition , 2015, Cancer biology & therapy.
[21] Wei Zhang,et al. Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas. , 2014, International journal of clinical and experimental pathology.
[22] P. Lu,et al. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression , 2014, International journal of cancer.
[23] S. Jiang,et al. Prognostic CpG Methylation Biomarkers Identified by Methylation Array in Esophageal Squamous Cell Carcinoma Patients , 2014, International journal of medical sciences.
[24] B. Wollenberg,et al. Stem cell profiling in head and neck cancer reveals an Oct-4 expressing subpopulation with properties of chemoresistance. , 2014, Oral oncology.
[25] Peter M. Schlag,et al. Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer , 2013, Molecular oncology.
[26] Ming-Sound Tsao,et al. An overview of the c-MET signaling pathway , 2011, Therapeutic advances in medical oncology.
[27] Pei-Rong Wang,et al. Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. , 2011, Cell stem cell.
[28] Ruixue Yang,et al. The expression of metastasis-associated in colon cancer-1, Snail, and KAI1 in esophageal carcinoma and their clinical significance. , 2019, International journal of clinical and experimental pathology.
[29] Feng Yan,et al. Overexpression of Metastasis-Associated in Colon Cancer-1 Associated with Poor Prognosis in Patients with Esophageal Cancer , 2013 .
[30] W. Birchmeier,et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis , 2009, Nature Medicine.